Form 8-K - Current report:
SEC Accession No. 0000950170-25-110952
Filing Date
2025-08-22
Accepted
2025-08-22 16:07:27
Documents
20
Period of Report
2025-08-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ivvd-20250820.htm   iXBRL 8-K 74966
2 EX-1.1 ivvd-ex1_1.htm EX-1.1 568452
3 EX-4.1 ivvd-ex4_1.htm EX-4.1 182258
4 EX-5.1 ivvd-ex5_1.htm EX-5.1 23286
5 EX-99.1 ivvd-ex99_1.htm EX-99.1 15197
6 EX-99.2 ivvd-ex99_2.htm EX-99.2 17307
7 EX-99.3 ivvd-ex99_3.htm EX-99.3 16092
8 GRAPHIC img59752938_0.jpg GRAPHIC 85687
9 GRAPHIC img60430933_0.jpg GRAPHIC 28105
10 GRAPHIC img60676459_0.jpg GRAPHIC 85687
11 GRAPHIC img61599980_0.jpg GRAPHIC 85687
  Complete submission text file 0000950170-25-110952.txt   1534334

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT ivvd-20250820.xsd EX-101.SCH 31866
22 EXTRACTED XBRL INSTANCE DOCUMENT ivvd-20250820_htm.xml XML 4877
Mailing Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 178 WALTHAM MA 02451 (781) 819-0080
Invivyd, Inc. (Filer) CIK: 0001832038 (see all company filings)

EIN.: 851403134 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40703 | Film No.: 251246314
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)